These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2118261)

  • 1. Cost savings in cancer care from the selection of effective versus ineffective initial chemotherapy.
    Dickinson KD; Myers TJ
    Prog Clin Biol Res; 1990; 339():465-76. PubMed ID: 2118261
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacoeconomics of cancer therapies.
    Bishop JF; Macarounas-Kirchman K
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-106-S19-111. PubMed ID: 9427279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck.
    Lang K; Sussman M; Friedman M; Su J; Kan HJ; Mauro D; Tafesse E; Menzin J
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):582-8. PubMed ID: 19528407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data.
    Lang K; Menzin J; Earle CC; Jacobson J; Hsu MA
    Arch Otolaryngol Head Neck Surg; 2004 Nov; 130(11):1269-75. PubMed ID: 15545580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of pegfilgrastim versus filgrastim primary prophylaxis in women with early-stage breast cancer receiving chemotherapy in the United States.
    Lyman GH; Lalla A; Barron RL; Dubois RW
    Clin Ther; 2009 May; 31(5):1092-104. PubMed ID: 19539110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interpreting the economic literature in oncology.
    Grusenmeyer PA; Wong YN
    J Clin Oncol; 2007 Jan; 25(2):196-202. PubMed ID: 17210940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infusion versus perfusion.
    Golomb FM
    Aktuelle Probl Chir; 1970; 14():835-57. PubMed ID: 4124391
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial facts about treating breast cancer.
    Smith MD; McGhan WF
    Bus Health; 1996 Dec; 14(12):67-8, 70. PubMed ID: 10163993
    [No Abstract]   [Full Text] [Related]  

  • 9. Using comorbidity indexes to predict costs for head and neck cancer.
    Hollenbeak CS; Stack BC; Daley SM; Piccirillo JF
    Arch Otolaryngol Head Neck Surg; 2007 Jan; 133(1):24-7. PubMed ID: 17224517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.
    Orr JW; Orr P; Kern DH
    Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is adjuvant therapy for older patients with node (-) early breast cancer cost-effective?
    Naeim A; Keeler EB
    Crit Rev Oncol Hematol; 2005 Jan; 53(1):81-9. PubMed ID: 15607936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical expenditures of terminal cancer patients during the last year of life.
    Long SH; Gibbs JO; Crozier JP; Cooper DI; Newman JF; Larsen AM
    Inquiry; 1984; 21(4):315-27. PubMed ID: 6240463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why managed care should provide supportive therapies for cancer patients.
    Rubenstein SA
    Manag Care; 1995 Aug; 4(8):37-9. PubMed ID: 10145013
    [No Abstract]   [Full Text] [Related]  

  • 14. Standard chemotherapy in squamous cell head and neck cancer: what we have learned from randomized trials.
    Browman GP; Cronin L
    Semin Oncol; 1994 Jun; 21(3):311-9. PubMed ID: 7516093
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of chemotherapy in squamous cell cancer of the head and neck (author's transl)].
    Schröder M; von Heyden HW
    HNO; 1981 Jul; 29(7):225-39. PubMed ID: 7021487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economics of squamous cell carcinoma of the head and neck.
    Menzin J; Lines LM; Manning LN
    Curr Opin Otolaryngol Head Neck Surg; 2007 Apr; 15(2):68-73. PubMed ID: 17413405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoradiation of malignant tumors presensitized with hematoporphyrin derivative.
    McCaughan JS
    Prog Clin Biol Res; 1984; 170():805-27. PubMed ID: 6241717
    [No Abstract]   [Full Text] [Related]  

  • 18. News from "the real world": cost-effectiveness in palliative care.
    Support Care Cancer; 1994 Jul; 2(4):211-2. PubMed ID: 7522105
    [No Abstract]   [Full Text] [Related]  

  • 19. Curative cancer chemotherapy.
    Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6523-37. PubMed ID: 2998603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.